The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

JPMorgan Chase, Wells Fargo and BlackRock reported strong quarterly results to kick off earnings season, but concerns linger ...

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

辉瑞CEO Albert Bourla最近有点烦。 不仅是因为公司业绩持续下滑，还有近日著名的激进投资者Starboard Value盯上了辉瑞，CEO或面临“下台”风险。 激进投资者（Activist ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

That activist investor is veteran corporate gadfly Starboard Value, which made its letter public just before market open. In it, Starboard confirmed its status as a Pfizer shareholder and, as the ...

Former Pfizer CEO Ian Read and former CFO Frank D’Amelio announced their withdrawal from Starboard Value’s activist campaign ...

Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for ...

On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board ...

Starboard’s Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as ...

Starboard Value LP (together with its affiliates, "Starboard" or "we"), a significant shareholder of Pfizer Inc. (NYSE: PFE) ("Pfizer" or the "Company"), today issued the below letter to Company's ...